Please be aware that this is a co-op position runs for 5 months, from July 10th – December 20th. Please only apply if you are able to commit to this timeframe. Also, Wentworth’s policy is that you are not taking classes when on co-op.
This position was found by C&C staff on LinkedIn. If the link is broken, please email us the Job ID# to hire@wit.edu.
The Vertex Co-op Program offers students the opportunity to learn about the pharmaceutical industry from a hands-on perspective. You will be working closely with and learning from some of the brightest people in the industry. When you join our co-op program you should not be surprised to see that our environment is one that is innovative and team oriented, where collaboration is not just a word, and “we are relentless” is in everything we do. Students can expect to be challenged by their project plan, connect with other co-ops, and feel valued by the Vertex community. Not only will co-ops learn about their day-to-day tasks through their specific work assignments, but they will interact and have exposure to our organizational leaders and their teams.
Job Summary:
Vertex Pharmaceuticals is working to discover and develop innovative genetic therapies with the potential to provide transformative benefit to patients. Vertex is currently advancing multiple CRISPR-based genetic therapies that have the potential to cure or stop the progression of degenerative and neuromuscular diseases. This internship will provide a fantastic opportunity to work on cutting edge science, apply state-of-the-art gene editing technologies, and take part in discovering and developing next-generation therapies for Duchenne Muscular Dystrophy and other genetic disorders.
The co-op role will be undertaken at Vertex Cell and Genetic Therapies, in a highly dynamic environment and competitive field. The overarching goal of this research role is to evaluate gene editing efficiency at disease genomic loci and to contribute to the development of systems for screening and delivery of next-generation therapeutic approaches. Projects related to roles within this group include evaluating novel gene editing delivery methods, characterizing in vitro model systems, exploratory research in new disease areas and development of next generation technologies for measuring gene editing outcomes. Successful candidates will be exposed to a broad range of advanced technologies including CRISPR-Cas9 genome engineering, cell culture, next generation sequencing, high content microscopy, and automated liquid-handling systems.
Key Responsibilities:
- Perform cell culture experiments to deliver gene editing assets
- Assess gene editing efficiency and cellular outcomes using endpoint readouts
- Document experimental procedures and findings in an accurate and timely manner
- Present results and conclusions to team members
- Experience or familiarity with gene editing, CRISPR/Cas9, human disease modeling, delivery systems